The Society for Immunotherapy of Cancer (SITC) is excited to
announce Rafi Ahmed, PhD, FAIO from
the Emory University School of Medicine
as the Keynote Speaker at its 39th Annual Meeting and
Pre-Conference Programs (SITC 2024). SITC is also hosting
Elizabeth M. Jaffee, MD, FAIO,
FAACR, FACP, FAAAS from the Sidney Kimmel Cancer Center at
Johns Hopkins, the 2024 recipient of
the Richard V. Smalley Memorial
Award and Lectureship, the society's most prestigious award and
which honors those who have been pioneers in their work and made a
notable impact on the field of cancer immunotherapy. Dr. Jaffee
will also give a presentation as a part of this award. The title of
her presentation is, "The Era of Cancer Vaccines Has Arrived."
MILWAUKEE, May 15, 2024
/PRNewswire-PRWeb/ -- The Society for Immunotherapy of Cancer
(SITC) is excited to announce Rafi
Ahmed, PhD, FAIO from the Emory
University School of Medicine as the Keynote Speaker at its
39th Annual Meeting and Pre-Conference Programs (SITC 2024). SITC
is also hosting Elizabeth M. Jaffee,
MD, FAIO, FAACR, FACP, FAAAS from the Sidney Kimmel Cancer Center
at Johns Hopkins, the 2024 recipient of
the Richard V. Smalley Memorial
Award and Lectureship, the society's most prestigious award and
which honors those who have been pioneers in their work and made a
notable impact on the field of cancer immunotherapy. Dr. Jaffee
will also give a presentation as a part of this award. The title of
her presentation is, "The Era of Cancer Vaccines Has Arrived."
"We have curated an exceptional roster of
speakers in the field of immuno-oncology, poised to unveil the
latest scientific advancements propelling our discipline forward."
- Harriet Kluger, MD, Chair of the
2024 SITC Annual Program Committee
"SITC takes immense pride in uniting luminaries in cancer
immunotherapy to advance scientific frontiers and nurture the next
generation of immuno-oncology researchers and clinicians," remarked
Leisha A. Emens, MD, PhD, President
of SITC.
As the largest conference focused solely on cancer
immunotherapy, SITC 2024 will feature cutting-edge research
presentations by experts in the field, oral and poster abstract
presentations and ample opportunity for structured and informal
discussions, including important networking opportunities. The
meeting also includes updates on major national and international
initiatives coming from academia, government and industry.
"We have curated an exceptional roster of speakers in the field
of immuno-oncology, poised to unveil the latest scientific
advancements propelling our discipline forward," remarked
Harriet Kluger, MD, Chair of the
2024 SITC Annual Program Committee. "This period continues to be
transformative for cancer immunology and immunotherapy, and the
innovative science, dynamic interactions, and collaborative
opportunities emblematic of SITC Annual Meetings will undoubtedly
help attendees pioneer novel treatments for cancer patients."
Visit http://www.sitcancer.org/2024 for the latest updates and
to register for SITC's 39th Annual Meeting & Pre-Conference
Programs, being held from Nov. 6–10, 2024, at the George R. Brown
Convention Center in Houston, TX.
Virtual participation is also available. Visit
http://www.sitcancer.org for more information on this event and
other SITC resources.
SITC 2024 attendees will:
- Participate in key scientific sessions focused on a variety of
basic-, translational- and clinical-focused topics from leaders in
the field
- Learn about cutting-edge research via oral abstract
presentations and poster presentations – the 38th Annual Meeting
had over 1,500 abstract submissions
- Engage with industry representatives and learn about the latest
technological advances in our exhibit hall
- Earn continuing education credits
- Connect with other SITC 2024 attendees from around the
world
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC)
is a nonprofit organization of medical professionals dedicated to
improving cancer patient outcomes by advancing the development,
science and application of cancer immunotherapy and tumor
immunology. SITC is comprised of influential basic and
translational scientists, practitioners, health care professionals,
government leaders and industry professionals around the globe.
Through educational initiatives that foster scientific exchange and
collaboration among leaders in the field, SITC aims to one day make
the word "cure" a reality for cancer patients everywhere. Learn
more about SITC, our educational offerings and other resources at
sitcancer.org and follow us on X, LinkedIn, Facebook and
YouTube.
Media Contact
Thomas Martin, Society for
Immunotherapy of Cancer, 414-271-2456, tmartin@sitcancer.org,
www.sitcancer.org
Twitter LinkedIn
View original content to download
multimedia:https://www.prweb.com/releases/sitc-announces-keynote-speakers-dr-rafi-ahmed-and-dr-elizabeth-m-jaffee-at-its-39th-annual-meeting-302146533.html
SOURCE Society for Immunotherapy of Cancer